Molecule News and Research

RSS

Researchers report near-atomic-resolution images of nitrogenase during catalysis using cryo-EM

Previously, it has been impossible to capture the high-resolution images of nitrogenase, the only enzyme capable of reducing nitrogen into ammonia, during catalytic action.

29 Jul 2022

Mesoporous silica nanoparticles: Possibilities in therapeutic development

In this interview, News-Medical talks to Philippe Riviere, Senior Scientist at NanoComposix (now a Fortis Life Sciences company) about mesoporous silica nanoparticles and the possibilities and opportunities they provide to drug delivery, vaccine development and more.

From nanoComposix 28 Jul 2022

Researchers unravel how one gut bacterium influences immunity

From immunity to metabolism to mental health, it seems like the gut microbiome has been linked to every aspect of human health and disease.

27 Jul 2022

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Researchers assessed the biodistribution and safety of SBCoV202, a novel antiviral agent based on antisense technology that can specifically and effectively bind to the SARS-CoV-2 genome target to inhibit SARS-CoV-2 replication.

27 Jul 2022

Study confirms link between Epstein-Barr virus and multiple sclerosis

Researchers investigate the association between Epstein-Barr virus infection and multiple sclerosis.

26 Jul 2022

New 'decoy receptor' molecules inhibit growth of multiple myeloma and diffuse large B cell lymphoma in mice

Researchers at Stanford University have developed "decoy receptor" molecules that inhibit the growth of both multiple myeloma (MM) and diffuse large B cell lymphoma (DLBCL) in mice.

26 Jul 2022

Using CRISPR to Lift the Lid on Probiotics

In this interview, we speak to Echo Pan, a Ph.D. student from North Carolina State University about her latest research that used CRISPR to uncover more on probiotics.

26 Jul 2022

How COVID-19 affects the brain microvasculature

A recent study discusses the effects of COVID-19 on the brain microvascular system.

25 Jul 2022

Researchers investigate a drug used for neuromuscular weakness as potential treatment for botulism

Wake Forest Institute for Regenerative Medicine (WFIRM) researchers are investigating a drug used to treat neuromuscular weakness as a potential treatment for botulism, a rare but serious disease.

25 Jul 2022

Study suggests a possible treatment approach for cancer and cardiovascular disease

A key molecule for cancer metastasis has been identified as a molecule already known for its involvement in cardiovascular disease, suggesting a possible treatment approach for both diseases simultaneously.

25 Jul 2022

Research reveals molecular clues associated with traumatic brain injury

New research led by scientists at Arizona State University has revealed some of the first detailed molecular clues associated with one of the leading causes of death and disability, a condition known as traumatic brain injury (TBI).

23 Jul 2022

Defect in a protein causes motor disorders in flies

Researchers at the Universities of Bonn and Osnabrück have discovered a protein whose defect causes motor disorders in flies.

22 Jul 2022

Study reveals new mechanism that regulates auditory sensitivity

A new study published in PNAS highlights a newly identified mechanism of how auditory sensitivity is regulated that could temporarily reduce sensitivity of the auditory system to protect itself from loud sounds that can cause irreversible damage.

22 Jul 2022

UTHSC investigators secure $2.16 million to test a new way to combat neurodegenerative disorders

The National Institute on Aging recently awarded $2.16 million to a team of investigators from the University of Tennessee Health Science Center (UTHSC) testing a new way to combat the root cause of neurodegenerative disorders such as Alzheimer's Disease.

22 Jul 2022

Study reveals pathway in the brain that leads to social instigation

When male animals spend time around other males of the same species, subsequent aggressive behavior tends to be amplified - this type of priming is known as social instigation.

22 Jul 2022

New AI software can create proteins that may be useful as vaccines, cancer treatments

Scientists have developed artificial intelligence software that can create proteins that may be useful as vaccines, cancer treatments, or even tools for pulling carbon pollution out of the air.

21 Jul 2022

Researchers discover a concise way to synthesize potent natural neurotoxin

Researchers have discovered a concise way to synthesize a "biosynthetic and ecological enigma" that has intrigued chemists and biologists for more than a century: tetrodotoxin (TTX), a potent natural neurotoxin commonly associated with pufferfish that is also used as a vital probe in neuroscience research.

21 Jul 2022

Molecule News and Research

Researchers report near-atomic-resolution images of nitrogenase during catalysis using cryo-EM

Mesoporous silica nanoparticles: Possibilities in therapeutic development

Researchers unravel how one gut bacterium influences immunity

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Study confirms link between Epstein-Barr virus and multiple sclerosis

New 'decoy receptor' molecules inhibit growth of multiple myeloma and diffuse large B cell lymphoma in mice

Using CRISPR to Lift the Lid on Probiotics

How COVID-19 affects the brain microvasculature

Researchers investigate a drug used for neuromuscular weakness as potential treatment for botulism

Study suggests a possible treatment approach for cancer and cardiovascular disease

Research reveals molecular clues associated with traumatic brain injury

Defect in a protein causes motor disorders in flies

Study reveals new mechanism that regulates auditory sensitivity

UTHSC investigators secure $2.16 million to test a new way to combat neurodegenerative disorders

Study reveals pathway in the brain that leads to social instigation

New AI software can create proteins that may be useful as vaccines, cancer treatments

Researchers discover a concise way to synthesize potent natural neurotoxin

Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

Stopping 'budding' viruses in their tracks

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News